Nociceptive sensory nerves suppress anti-tumor immunity by blocking tertiary lymphoid structure formation in lung cancer
By
Leanne Li1,20 Send email to [email protected]
Summary
This study investigates the role of nociceptive sensory innervation in lung adenocarcinoma (LUAD). The researchers found that LUAD progression amplifies nociceptive sensory neurons, which release the neuropeptide CGRP. CGRP acts on a subset of macrophages, impairing the recruitment of CXCL13+ fibroblasts and blocking the formation of tertiary lymphoid structures (TLS)—a key predictor of LUAD prognosis. Local sensory denervation restores TLS formation and enhances B and T cell anti-tumor immunity. The study identifies CGRP signaling as a druggable, smoking-linked vulnerability that could enhance immunotherapy response in lung cancer preclinical models.
Source
bskyNociceptive sensory nerves suppress anti-tumor immunity by blocking tertiary lymphoid structure formation in lung cancercell.comKey quotes
· 4 pulledNociceptive innervation limits tertiary lymphoid structures to promote lung cancer
CGRP acts on a subset of macrophages, thereby impairing the recruitment of CXCL13+ fibroblasts and blocking tertiary lymphoid structure (TLS) assembly, a key predictor of LUAD prognosis
Local sensory denervation restores TLS formation, enhances B and T cell anti-tumor immunity
This study reveals CGRP signaling as a druggable, smoking-linked vulnerability for enhancing immunotherapy response in lung cancer preclinical models
You might also wanna read

Pan-cancer AI atlas reveals diversity and spatial organization of tertiary lymphoid structures in tumors
Researchers built a pan-cancer atlas of tertiary lymphoid structures (TLSs) in human tumors, developing an AI-based framework to detect and
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
A post hoc analysis of pooled data from two clinical trials found that the CGRP monoclonal antibody fremanezumab reduces the risk of weather

Study reveals how immunotherapy can drive immune evasion in pancreatic cancer through Treg cell activity and MHC-I suppression
This study investigates mechanisms driving immunotherapy resistance in pancreatic ductal adenocarcinoma (PDA). Using murine models, the rese

Mayo Clinic study reveals immune cells begin preparing to fight cancer earlier than thought
Mayo Clinic researchers have discovered that some cancer-fighting immune cells (T cells) begin preparing to fight cancer much earlier than p

Study reveals how immunotherapy can drive immune evasion in pancreatic cancer through Treg cell activity and MHC-I suppression
This study investigates mechanisms driving immunotherapy resistance in pancreatic ductal adenocarcinoma (PDA). Using murine models, the rese

CD4+ T cells and macrophages collaborate to cut off tumor blood supply via IL-3 and TNF signaling
This study by Lian et al. reveals a novel mechanism by which CD4+ T cells and macrophages collaborate to impair tumor growth. CD4+ T cells r

Comments
Sign in to join the conversation.
No comments yet. Be the first.